Home Galena Biopharma Raised to "Outperform" at Oppenheimer
 

Keywords :   


Galena Biopharma Raised to "Outperform" at Oppenheimer

2015-11-15 17:14:57| Biotech - Topix.net

The brokerage currently has a $4.00 price target on the biotechnology company's stock. Oppenheimer's target price suggests a potential upside of 166.67% from the company's previous close.

Tags: raised outperform oppenheimer biopharma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Acreage and stocks estimates push corn prices lower
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
More »